top of page

Author Guidelines

International Journal for Gynecology and Pediatrics Research (IJGPR)

ISSN-E: 3139-7654
Website: https://www.ijgpr.com/
Email: editor@ijgpr.com

​

1. About the Journal

The International Journal for Gynecology and Pediatrics Research (IJGPR) is an international, peer-reviewed, open-access journal dedicated to the publication of high-quality scientific research in gynecology, obstetrics, pediatrics, neonatology, reproductive health, maternal and child health, and related biomedical and clinical disciplines.

IJGPR aims to provide a scholarly platform for clinicians, researchers, academicians, healthcare professionals, and scientists to disseminate original findings, clinical observations, systematic evidence, and advances that contribute to improving women's, maternal, neonatal, pediatric, and adolescent health.

2. Aims and Scope

The journal welcomes original and clinically relevant research covering all aspects of Gynecology, Obstetrics, Pediatrics, Neonatology, Reproductive Medicine, and Maternal & Child Health.

Major Subject Areas

Manuscripts may include, but are not limited to:

  • Obstetrics

  • General Gynecology

  • Maternal–Fetal Medicine

  • Reproductive Medicine

  • Reproductive Endocrinology

  • Infertility

  • Assisted Reproductive Technology (ART)

  • Gynecological Endocrinology

  • Gynecological Oncology

  • Urogynecology

  • Menstrual Disorders

  • Endometriosis and Adenomyosis

  • Polycystic Ovary Syndrome (PCOS)

  • Menopause

  • Contraception and Family Planning

  • High-Risk Pregnancy

  • Prenatal Diagnosis and Screening

  • Fetal Medicine

  • Labor and Delivery

  • Postpartum Care

  • Maternal Health

  • General Pediatrics

  • Neonatology

  • Pediatric Emergency Medicine

  • Pediatric Critical Care

  • Pediatric Cardiology

  • Pediatric Neurology

  • Pediatric Gastroenterology

  • Pediatric Nephrology

  • Pediatric Endocrinology

  • Pediatric Hematology and Oncology

  • Pediatric Infectious Diseases

  • Pediatric Respiratory Medicine

  • Pediatric Genetics

  • Pediatric Immunology and Rheumatology

  • Pediatric Dermatology

  • Growth and Development

  • Nutrition and Malnutrition

  • Immunization

  • Adolescent Medicine

  • Developmental and Behavioral Pediatrics

  • Child and Adolescent Mental Health

  • Community Pediatrics

  • Pediatric Surgery and related clinical research

  • Maternal and Child Public Health

  • Medical Genetics and Genomics

  • Clinical Pharmacology related to women and children

  • Evidence-Based Women's and Children's Healthcare

  • Medical Education related to Gynecology and Pediatrics

Interdisciplinary research relevant to women's, maternal, neonatal, pediatric, and adolescent health is also encouraged.

​

3. Publication Ethics

IJGPR expects authors, reviewers, and editors to maintain high standards of scientific and publication integrity.

Authors are encouraged to follow relevant international principles and reporting standards, including:

  • ICMJE Recommendations

  • COPE Principles and Core Practices

  • Declaration of Helsinki

  • CONSORT Statement

  • STROBE Guidelines

  • PRISMA Statement

  • CARE Guidelines

  • ARRIVE Guidelines

  • EQUATOR Network reporting guidelines

Fabrication, falsification, plagiarism, inappropriate image manipulation, duplicate publication, undisclosed conflicts of interest, and other forms of research misconduct are not acceptable.

​

4. Types of Manuscripts

IJGPR accepts the following categories:

  • Original Research Articles

  • Clinical Research Articles

  • Review Articles

  • Systematic Reviews

  • Meta-Analyses

  • Randomized Controlled Trials

  • Observational Studies

  • Cohort Studies

  • Case-Control Studies

  • Cross-Sectional Studies

  • Case Reports

  • Case Series

  • Short Communications

  • Brief Reports

  • Technical Reports

  • Clinical Images

  • Perspective Articles

  • Editorials

  • Letters to the Editor

The Editorial Board may consider other scientifically relevant manuscript categories at its discretion.

​

5. Manuscript Preparation

Language

Manuscripts should be written in clear and professional English.

Authors are responsible for ensuring appropriate grammar, scientific terminology, and clarity before submission.

File Format

Manuscripts should preferably be submitted in:

Microsoft Word (.doc or .docx)

General Formatting

  • Font: Times New Roman

  • Font Size: 12 pt

  • Line Spacing: 1.5

  • Margins: 1 inch on all sides

  • Page Numbers: Recommended

  • Abbreviations: Define at first use

​

6. Manuscript Structure

6.1 Title Page

The title page should contain:

  • Full manuscript title

  • Full names of all authors

  • Institutional affiliations

  • Department

  • City and country

  • ORCID IDs, where available

  • Corresponding author's name

  • Corresponding author's email address

  • Contact number

  • Funding information

  • Conflict of Interest declaration

The title should be concise, informative, and accurately represent the study.

6.2 Abstract

Original research articles should preferably include a structured abstract of up to 250 words.

Recommended headings:

  • Background

  • Objectives

  • Methods

  • Results

  • Conclusion

For manuscript types where a structured abstract is inappropriate, an unstructured abstract may be accepted.

​

Keywords

Authors should provide approximately 3–8 keywords immediately after the abstract.

​

7. Main Manuscript

Original clinical and experimental research should generally follow the following structure:

  1. Introduction

  2. Materials and Methods

  3. Results

  4. Discussion

  5. Conclusion

  6. Limitations

  7. Future Scope, where applicable

  8. Acknowledgments

  9. Funding

  10. Conflict of Interest

  11. Author Contributions

  12. Ethical Approval

  13. Informed Consent

  14. Data Availability Statement

  15. References

The structure may be modified appropriately for reviews, case reports, systematic reviews, meta-analyses, and other manuscript categories.

​

8. Ethical Requirements

Research involving human participants must comply with applicable ethical standards and the principles of the Declaration of Helsinki.

Authors should provide, where applicable:

  • Name of the Institutional Ethics Committee/Institutional Review Board

  • Ethics approval/reference number

  • Date of approval, where available

  • Statement regarding informed consent

  • Patient consent for publication where identifiable clinical information or images are presented

For retrospective studies where consent or ethical approval has been waived, the manuscript should clearly state the waiver and the authority granting it.

​

Animal Research

Studies involving animals should include:

  • Institutional Animal Ethics Committee approval

  • Approval/reference number

  • Statement regarding compliance with applicable animal welfare standards

​

Clinical Trials

Prospective clinical trials should provide an appropriate trial registration number and registry information where required.

9. Patient Privacy and Consent

Authors must protect patient confidentiality.

Names, hospital identification numbers, facial features, or other information that could identify an individual should not be published unless scientifically necessary and appropriate written consent for publication has been obtained.

For case reports and identifiable clinical images, authors should obtain appropriate patient or guardian consent before submission.

For pediatric patients, consent requirements should be fulfilled through the parent or legally authorized guardian as applicable.

10. Plagiarism and Originality Policy

All manuscripts submitted to IJGPR should represent original scholarly work.

Submissions may undergo similarity screening before or during editorial evaluation.

As a journal policy:

  • Overall similarity should normally be ≤10%, excluding references and unavoidable standard methodological terminology.

  • Excessive similarity from a single source should be avoided.

  • Manuscripts with inappropriate text duplication may be returned for correction or rejected.

  • Plagiarism, fabrication, falsification, and duplicate publication are prohibited.

Similarity percentages are used as screening indicators and do not replace editorial assessment of the nature and context of any textual overlap.

11. Artificial Intelligence (AI) Policy

Generative artificial intelligence and AI-assisted technologies may be used responsibly for purposes such as language improvement, grammar correction, or formatting.

However:

  • AI tools cannot be listed as authors.

  • Authors remain fully accountable for the accuracy and integrity of their manuscript.

  • AI-generated references or factual statements must be independently verified.

  • Confidential manuscript, patient, or research data should not be improperly disclosed to external AI systems.

  • Substantial use of generative AI in manuscript preparation should be transparently disclosed where appropriate.

AI tools must not replace human responsibility for scientific interpretation, authorship, or research integrity.

12. Figures and Images

Figures should be clear and suitable for publication.

Recommended requirements:

  • Minimum resolution: 300 dpi

  • Preferred formats: TIFF, PNG, or JPEG

  • Figures should be numbered consecutively

  • Each figure should have an appropriate legend

  • Figure citations should appear in numerical order in the manuscript

Authors are responsible for obtaining permission to reproduce previously published copyrighted material.

Clinical photographs must comply with patient privacy and consent requirements.

13. Tables

Tables should:

  • Be provided in editable format

  • Be numbered consecutively

  • Have a clear and concise title

  • Include explanatory footnotes where necessary

  • Be cited sequentially within the manuscript

Avoid submitting tables solely as images where editable versions can reasonably be provided.

14. References

IJGPR recommends the Vancouver referencing style.

References should be numbered according to their first appearance in the manuscript.

Authors should:

  • Verify every reference before submission.

  • Ensure that references cited in the text appear in the reference list.

  • Provide DOI numbers whenever available.

  • Avoid inaccurate, unverifiable, or fabricated references.

  • Prefer relevant primary and peer-reviewed scientific literature where appropriate.

15. Reporting Guidelines

Authors should use the reporting guideline appropriate to their study design whenever applicable.

Examples include:

  • CONSORT – Randomized controlled trials

  • STROBE – Observational studies

  • PRISMA – Systematic reviews and meta-analyses

  • CARE – Case reports

  • ARRIVE – Animal research

  • Other relevant EQUATOR Network guidelines

Authors may be requested to provide the relevant reporting checklist during editorial assessment.

​

16. Peer Review Process

IJGPR follows a double-blind peer-review process, with reviewer and author identities concealed from one another as far as practicable.

The general editorial workflow is:

Manuscript Submission

↓

Initial Editorial Screening

↓

Similarity and Compliance Check

↓

Assignment to Editor

↓

External Peer Review

↓

Author Revision, if required

↓

Editorial Re-evaluation

↓

Final Editorial Decision

↓

Production and Proof Preparation

↓

Online Publication

Acceptance is based on scientific quality, originality, methodological soundness, ethical compliance, relevance to the journal's scope, and peer-review recommendations.

​

17. Editorial Decisions

Following editorial assessment and peer review, manuscripts may receive one of the following decisions:

  • Accept

  • Minor Revision

  • Major Revision

  • Reject

Submission of a manuscript does not guarantee acceptance or publication.

18. Conflict of Interest

All authors must disclose any financial, professional, institutional, or personal relationships that could reasonably be perceived as influencing the research.

If no conflict exists, authors may state:

“The authors declare no conflict of interest.”

19. Funding Statement

All sources of financial support should be disclosed.

If the study received no specific funding, authors may state:

“This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.”

20. Author Contributions

Authors should describe their individual contributions to the work.

Contributions may include:

  • Conceptualization

  • Methodology

  • Investigation

  • Data Collection

  • Data Analysis

  • Validation

  • Writing – Original Draft

  • Writing – Review and Editing

  • Visualization

  • Supervision

  • Project Administration

All listed authors should meet appropriate authorship criteria and approve the final manuscript.

​

21. Data Availability Statement

Authors should provide a statement describing the availability of data supporting the findings of their research.

Where ethical, privacy, legal, or institutional restrictions prevent public sharing, these restrictions should be clearly stated.

22. Copyright

Authors retain copyright unless otherwise specified in the applicable publishing agreement.

Following acceptance, authors grant the journal/publisher the rights necessary to publish, distribute, archive, and disseminate the article according to the journal's publishing and open-access policies.

Authors are responsible for ensuring that submitted material does not infringe third-party copyright.

23. Open Access Policy

The International Journal for Gynecology and Pediatrics Research (IJGPR) operates under an open-access publishing model.

Published articles are made freely accessible online to support the dissemination and exchange of scientific and clinical knowledge.

The applicable license and reuse conditions should be displayed with each published article.

24. Corrections, Retractions, and Editorial Actions

IJGPR may issue corrections, expressions of concern, retractions, or other appropriate editorial notices when necessary to maintain the integrity of the scholarly record.

Such actions will be considered in accordance with established publication-ethics principles and the circumstances of each case.

​

25. Submission Checklist

Before submitting a manuscript, authors should ensure that the following items are complete:

  • Title page

  • Complete author names and affiliations

  • Corresponding author information

  • ORCID IDs, where available

  • Abstract

  • 3–8 keywords

  • Main manuscript

  • Figures and legends

  • Editable tables

  • References

  • Ethical approval statement, where applicable

  • Informed consent statement, where applicable

  • Patient/guardian consent for publication, where applicable

  • Clinical trial registration, where applicable

  • Funding statement

  • Conflict of Interest statement

  • Author Contribution statement

  • Data Availability statement

  • Acknowledgments, where applicable

  • AI-use disclosure, where applicable

​

26. Manuscript Submission

Authors should prepare manuscripts according to these guidelines and submit them through the submission mechanism provided on the journal website or according to instructions issued by the Editorial Office.

Website: https://www.ijgpr.com/

For manuscript-related queries, authors may contact:

Email: editor@ijgpr.com

​

Article Processing Charge (APC)

  • Submission Fee: ₹0 (No Submission Fee)

  • Publication Fee (after acceptance)

  • Article Type: APC

  • Original Research ₹10,000

  • Review Article ₹10,000

  • Systematic Review ₹10,000

  • Meta-analysis ₹10,000

  • Case Report ₹10,000

  • Short Communication ₹10,000

  • International Charge: 120 USD

​

Editorial Office

International Journal for Gynecology and Pediatrics Research (IJGPR)

ISSN-E: 3139-7654
Website: https://www.ijgpr.com/
Email: editor@ijgpr.com

​

Publshres

Cerebral Publication Private Limited

CIN: U58111DL2025PTC459104

Registered Office: 

2-A/3 S/F Front Side

Asaf Ali Road, Turkman, Gate

New Delhi, India -110002

Email: info@CerebralPublication.Com

Contact No: +91-9932010951

  • Black Facebook Icon
  • Black Twitter Icon
  • Black Instagram Icon
DOI.png
openalex-lockup.png
88x31 (1).png

Sitemap | Editorial and Ethical Policies | Open Access
| Advertise | Feedback | Disclaimer
©2025 | IJGPR | Published by Cerebral Publication Private Limited | IJGPR is licensed under a Creative Commons Attribution-Non Commercial-Share Alike 4.0 International License.

Copyright | 2026 by International Journal for Genecology and Pediatrics Research | www.IJGPR.Com

bottom of page